JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M600539200 on March 13, 2006

J. Biol. Chem., Vol. 281, Issue 24, 16207-16219, June 16, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/24/16207    most recent
M600539200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wajapeyee, N.
Right arrow Articles by Somasundaram, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wajapeyee, N.
Right arrow Articles by Somasundaram, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Apoptosis Induction by Activator Protein 2{alpha} Involves Transcriptional Repression of Bcl-2*Formula

Narendra Wajapeyee1, Ramona Britto, Halasahalli M. Ravishankar, and Kumaravel Somasundaram2

From the Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560 012, India

Activator protein 2{alpha} (AP-2{alpha}) induces cytotoxicity by inducing cell cycle arrest and apoptosis. In this study we investigated the mechanism of apoptosis induction by AP-2{alpha}. We found that AP-2{alpha} induced apoptosis efficiently in cells treated with benzyloxycar-bonyl-IETD-fluoromethyl ketone or FADD-silenced cells but failed to do so in benzyloxycarbonyl-LEHD-fluoromethyl ketone-treated or apoptosis protease activation factor-1 (Apaf1)-silenced cells, suggesting the central role of mitochondria in AP-2{alpha}-induced apoptosis. In good correlation, cells overexpressing AP-2{alpha} showed a reduction in mitochondrial membrane potential ({Delta}{psi}m), cytochrome c and Smac/DIABLO release into cytosol, and Bax translocation into mitochondria. We found that the pro-apoptotic protein Bax is important for AP-2{alpha}-induced apoptosis as adenovirus AP2 failed to induce apoptosis in HCT116 Bax–/– cells. However, we found the IAP (inhibitor of apoptosis) inhibitor Smac/DIABLO may have a limited role in AP-2{alpha}-induced apoptosis as we found the IAP member Survivin down-regulated by AP-2{alpha}. Although the total Bax level remains unaltered, we found a time-dependent increase in the activated form of Bax in adenovirus AP2-infected cells. In addition, we show that AP-2{alpha} transcriptionally represses Bcl-2 by binding to its promoter both in vitro and in vivo and that this is essential for AP-2{alpha}-induced apoptosis as ectopic expression of Bcl-2 efficiently inhibited apoptosis induced by AP-2{alpha}. Furthermore, we show that chemotherapy-induced endogenous AP-2{alpha} down-regulates Bcl-2 and induces apoptosis in an AP-2{alpha}-dependent manner. Moreover, we demonstrate that inhibition of okadaic acid or staurosporine-sensitive pathways in AP-2{alpha} overexpressing breast cancer cells resulted in AP-2{alpha}-dependent apoptosis induction. These results suggest that AP-2{alpha} induces apoptosis by down-regulating Bcl-2 and utilizing a bax/cytochrome c/Apaf1/caspase 9-dependent mitochondrial pathway.


Received for publication, January 18, 2006 , and in revised form, March 8, 2006.

* This work was supported by ICMR (Center for Advanced studies in Molecular Medicine), DBT (Program support and Expression Profiling), DST (FIST), and University Grants Commission (Special assistance). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.

1 Supported by a fellowship from University Grants Commission, Government of India.

2 A Wellcome Trust International Senior Research Fellow. To whom correspondence should be addressed. Tel.: 91-80-22932973; Fax: 91-80-23602697; E-mail: skumar{at}mcbl.iisc.ernet.in.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
F. Orso, E. Penna, D. Cimino, E. Astanina, F. Maione, D. Valdembri, E. Giraudo, G. Serini, P. Sismondi, M. De Bortoli, et al.
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs
FASEB J, August 1, 2008; 22(8): 2702 - 2714.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
H.-J. Choi, T.-W. Chung, S.-J. Kim, S.-Y. Cho, Y.-S. Lee, Y.-C. Lee, J.-H. Ko, and C.-H. Kim
The AP-2{alpha} transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene
Glycobiology, May 1, 2008; 18(5): 395 - 407.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-G. Deng, G. Jayachandran, G. Wu, K. Xu, J. A. Roth, and L. Ji
Tumor-specific Activation of Human Telomerase Reverses Transcriptase Promoter Activity by Activating Enhancer-binding Protein-2beta in Human Lung Cancer Cells
J. Biol. Chem., September 7, 2007; 282(36): 26460 - 26470.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.